Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase II Study of Pembrolizumab and High-Dose Pemetrexed for the Treatment of Patients With Progressive Chordoma

Primary Objective: 1\. To determine objective response rate (ORR) according to RECIST v1.1 of pembrolizumab and high-dose pemetrexed in the treatment of patie…

ChordomasChordoma

Saint John's Cancer InstituteNCT06794645